Suppression of lung cancer cell invasion by LKB1 is due to the downregulation of tissue factor and vascular endothelial growth factor, partly dependent on SP1

International Journal of Oncology

Volumn 45, Issue 6, 2014, Pages 1989-1997

  Liang, Xuan ^a   Li, Zhao Lun ^a   Jiang, Li Li ^a   Guo, Qian Qian ^a   Liu, Meng Jie ^a   Nan, Ke Jun ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

A549 cells; Invasion; LKB1 STK11; Tissue factor; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; PROTEIN KINASE LKB1; THROMBOPLASTIN; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN; PROTEIN SERINE THREONINE KINASE; SP1 PROTEIN, HUMAN; STK11 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MIGRATION ASSAY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LUNG CANCER CELL LINE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE TRANSFECTION; TUMOR INVASION; WESTERN BLOTTING; LUNG CANCER; CELL MOTION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; SP1 TRANSCRIPTION FACTOR; THROMBOPLASTIN; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899552802     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2351     Document Type: Article

References (30)

1. Bennett A and White J: Improving care and quality of life for patients with lung cancer. Nursing Stand 28: 50-58, 2013.
2. Gutierrez-Fernandez A, Fueyo A, Folgueras AR, et al: Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res 68: 2755-2763, 2008.
3. Sugahara KN, Hirata T, Tanaka T, et al: Chondroitin sulfate E fragments enhance CD44 cleavage and CD44-dependent motility in tumor cells. Cancer Res 68: 7191-7199, 2008.
4. Ghaffar H, Sahin F, Sanchez-Cepedes M, et al: LKB1 protein expression in the evolution of glandular neoplasia of the lung. Clin Cancer Res 9: 2998-3003, 2003.
5. Jimenez AI, Fernandez P, Dominguez O, Dopazo A and Sanchez-Cespedes M: Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3′-phosphate kinase/PTEN pathway. Cancer Res 63: 1382-1388, 2003.
6. Marcus AI and Zhou W: LKB1 regulated pathways in lung cancer invasion and metastasis. J Thorac oncol 5: 1883-1886, 2010.
7. Liang X, Nan KJ and Xu QZ: Effect of small interfering RNA-induced LKB1 gene silencing on the biological behavior of lung carcinoma cells. Nan Fang Yi Ke Da Xue Xue Bao 27: 1303-1306, 2007 (In Chinese).
8. Liang X, Nan KJ, Li CL, Yao Y, Tian T and Wang SH: Effect of transfection of LKB1 on biological behavior of human lung adenocarcinoma cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24: 1140-1142, 2008 (In Chinese).
9. Liang X, Nan KJ, Li ZL and Xu QZ: Overexpression of the LKB1 gene inhibits lung carcinoma cell proliferation partly through degradation of c-myc protein. Oncol Rep 21: 925-931, 2009.
10. Ylikorkala A, Rossi DJ, Korsisaari N, et al: Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science 293: 1323-1326, 2001.
11. Brugarolas J and Kaelin WG Jr: Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes. Cancer Cell 6: 7-10, 2004.
12. Nakasaki T, Wada H, Shigemori C, et al: Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 69: 247-254, 2002.
13. Zhang J, Ding J, Zhang X, Shao X and Hao Z: Regulation of vascular endothelial growth factor (VEGF) production and angiogenesis by tissue factor (TF) in SGC-7901 gastric cancer cells. Cancer Biol Ther 4: 769-772, 2005.
14. Koomagi R and Volm M: Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer 79: 19-22, 1998.
15. Li ZL, Xu WJ, Tian PX, et al: Recombinant adenovirus-mediated RNA silencing of tissue factor expression in human islet: an in vitro study. Nan Fang Yi Ke Da Xue Xue Bao 27: 1299-1302, 2007 (In Chinese).
16. Ji H, Ramsey MR, Hayes DN, et al: LKB1 modulates lung cancer differentiation and metastasis. Nature 448: 807-810, 2007.
17. Xu C, Gui Q, Chen W, et al: Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo. J Exp Clin Cancer Res 30: 63, 2011.
18. Minamiya Y, Matsuzaki I, Sageshima M, et al: Expression of tissue factor mRNA and invasion of blood vessels by tumor cells in non-small cell lung cancer. Surg Today 34: 1-5, 2004.
19. Mohammadi B, Haghpanah V and Larijani B: A stochastic model of tumor angiogenesis. Comput Biol Med 38: 1007-1011, 2008.
20. Vokes E, Herbst R and Sandler A: Angiogenesis inhibition in the treatment of lung cancer. Clin Adv Hematol Oncol 4: 1-10, 2006.
21. Wang S, Liu H, Ren L, Pan Y and Zhang Y: Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference. Neoplasia 10: 399-407, 2008.
22. Rickles FR, Shoji M and Abe K: The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. Int J Hematol 73: 145-150, 2001.
23. Regina S, Rollin J, Blechet C, Iochmann S, Reverdiau P and Gruel Y: Tissue factor expression in non-small cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation. J Thorac Oncol 3: 689-697, 2008.
24. Poon RT, Lau CP, Ho JW, Yu WC, Fan ST and Wong J: Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin Cancer Res 9: 5339-5345, 2003.
25. Regina S, Valentin JB, Lachot S, Lemarie E, Rollin J and Gruel Y: Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN. Clin Chem 55: 1834-1842, 2009.
26. Han S and Roman J: COX-2 inhibitors suppress integrin alpha5 expression in human lung carcinoma cells through activation of Erk: involvement of Sp1 and AP-1 sites. Int J Cancer 116: 536-546, 2005.
27. Zhang J, Jia Z, Li Q, et al: Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. Cancer 109: 1478-1486, 2007.
28. Lutzner N, De-Castro AJ and Rosl F: Gene expression of the tumour suppressor LKB1 is mediated by Sp1, NF-Y and FOXO transcription factors. PLoS One 7: e32590, 2012.
29. Shi Q, Le X, Abbruzzese JL, et al: Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res 61: 4143-4154, 2001.
30. Ishibashi H, Nakagawa K, Onimaru M, et al: Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities. Cancer Res 60: 6531-6536, 2000.